Diagnosis of Pelizaeus-Merzbacher disease: detection of proteolipid protein gene copy number by real-time PCR

被引:18
作者
Regis, S
Grossi, S
Lualdi, S
Biancheri, R
Filocamo, M
机构
[1] Ist Giannina Gaslini, Lab Diag PrePostnatale Malattie Metab, I-16147 Genoa, Italy
[2] Univ Genoa, Ist Giannina Gaslini, Neuromuscular Dis Unit, I-16147 Genoa, Italy
关键词
real-time PCR; gene dosage; duplication; PMD; PLP1; gene;
D O I
10.1007/s10048-005-0214-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Duplication of the proteolipid protein gene (PLP1) is the most frequent cause of Pelizaeus-Merzbacher disease (PMD), a severe X-linked myelination disorder. We developed an assay for the detection of the PLP1 gene dosage by real-time quantitative PCR using the ABI Prism 7700 Sequence Detection System and the TaqMan chemistry. Copy number of the PLP1 gene was determined by the standard curve method using GAPDH as the reference gene. The assay was tested both on 50 normal controls and on 20 subjects whose PLP1 gene copy number was previously determined by quantitative fluorescent multiplex PCR. The procedure confirmed the expected results both on the male and female normal controls as well as on the 20 subjects previously tested. Ratios corresponding to the presence of one, two or three PLP1 gene copies, distributed in three non-overlapping ranges, were obtained by real-time PCR analysis. Subsequently, 29 DNA samples of putative PMD patients and possible female carriers, with unknown PLP1 gene dosage, were analysed. Five affected males carrying the PLP1 gene duplication and four female heterozygotes carrying three PLP1 gene copies were identified among them. The method is suitable for the identification of affected male patients and female carriers. Specific ranges are widely spaced, ensuring a correct assignment of the PLP1 gene copy number.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 28 条
[1]   Real-time quantitative polymerase chain reaction - A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies [J].
Aarskog, NK ;
Vedeler, CA .
HUMAN GENETICS, 2000, 107 (05) :494-498
[2]  
*APPL BIOS, 2001, US B APPL BIOS, V2
[3]   PROTEOLIPID PROTEIN GENE DOSAGE EFFECT IN PELIZAEUS-MERZBACHER DISEASE [J].
ELLIS, D ;
MALCOLM, S .
NATURE GENETICS, 1994, 6 (04) :333-334
[4]   The molecular pathogenesis of Pelizaeus-Merzbacher disease [J].
Garbern, J ;
Cambi, F ;
Shy, M ;
Kamholz, J .
ARCHIVES OF NEUROLOGY, 1999, 56 (10) :1210-1214
[5]   Prenatal diagnosis of Pelizaeus-Merzbacher disease [J].
Garbern, J ;
Hobson, G .
PRENATAL DIAGNOSIS, 2002, 22 (11) :1033-1035
[6]   Real time quantitative PCR [J].
Heid, CA ;
Stevens, J ;
Livak, KJ ;
Williams, PM .
GENOME RESEARCH, 1996, 6 (10) :986-994
[7]   Pelizaeus-Merzbacher disease and spastic paraplegia type 2: Two faces of myelin loss from mutations in the same gene [J].
Hudson, LD .
JOURNAL OF CHILD NEUROLOGY, 2003, 18 (09) :616-624
[8]  
HUDSON LD, 2001, METABOLIC MOL BASIS, P5789
[9]  
Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.0.CO
[10]  
2-1